Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Western New York Healthcare System at Buffalo
mi
from
Buffalo, NY
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Western New York Healthcare System at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Durham
mi
from
Durham, NC
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Durham
mi
from
Durham, NC
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Portland
mi
from
Portland, OR
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Health Care System
mi
from
Pittsburgh, PA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Health Care System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Ralph H Johnson VA Medical Center, Charleston
mi
from
Charleston, SC
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Ralph H Johnson VA Medical Center, Charleston
mi
from
Charleston, SC
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, Memphis
mi
from
Memphis, TN
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA North Texas Health Care System, Dallas
mi
from
Dallas, TX
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA North Texas Health Care System, Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA South Texas Health Care System, San Antonio
mi
from
San Antonio, TX
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA South Texas Health Care System, San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Health Care System, Salt Lake City
mi
from
Salt Lake City, UT
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Health Care System, Salt Lake City
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Wlliam S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Wlliam S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
VA Medical Center, San Juan
mi
from
San Juan,
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
VA Medical Center, San Juan
mi
from
San Juan,
Click here to add this to my saved trials
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated:  12/31/1969
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
North Little Rock, AR
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
CSP #553 - Adjuvant Therapy in Prostate Carcinoma Treatment
Status: Enrolling
Updated: 12/31/1969
Central Arkansas VHS Eugene J. Towbin Healthcare Ctr, Little Rock
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Stem Cell Transplant for Hematological Malignancy
Allogeneic Transplant for Hematological Malignancy
Status: Enrolling
Updated:  12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Stem Cell Transplant for Hematological Malignancy
Allogeneic Transplant for Hematological Malignancy
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Division of Endocrinology & Metabolism
mi
from
Baltimore, MD
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Division of Endocrinology & Metabolism
mi
from
Baltimore, MD
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Institute Gustave Roussy
mi
from
Paris,
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Institute Gustave Roussy
mi
from
Paris,
Click here to add this to my saved trials
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C
Status: Enrolling
Updated:  12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Microarray Analysis of Gene Expression in Prostate Tissues
Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)
Status: Enrolling
Updated:  12/31/1969
Stanford University Cancer Center
mi
from
Stanford, CA
Microarray Analysis of Gene Expression in Prostate Tissues
Microarray Analysis of Gene Expression in Prostate Tissues (Translating Prostate Cancer Gene Expression Sub-types)
Status: Enrolling
Updated: 12/31/1969
Stanford University Cancer Center
mi
from
Stanford, CA
Click here to add this to my saved trials
Radiation Therapy to Treat Musculoskeletal Tumors
Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects
Status: Enrolling
Updated:  12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Radiation Therapy to Treat Musculoskeletal Tumors
Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects
Status: Enrolling
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
A Randomized Placebo-controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients With a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy
Status: Enrolling
Updated:  12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
A Randomized Placebo-controlled Trial of Glutamine to Reduce the Signs and Symptoms of Peripheral Neuropathy in Breast Cancer Patients With a Mild Peripheral Neuropathy Receiving Paclitaxel Chemotherapy
Status: Enrolling
Updated: 12/31/1969
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Phase II Trial of Exemestane (Aromasin) in Combination With Fulvestrant (Faslodex) in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Phase II Trial of Exemestane (Aromasin) in Combination With Fulvestrant (Faslodex) in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Soy Protein and Breast Cancer Risk Reduction
Soybean Diet and Breast Density
Status: Enrolling
Updated:  12/31/1969
General Clinical Research Center, The University of Texas Medical Branch
mi
from
Galveston, TX
Soy Protein and Breast Cancer Risk Reduction
Soybean Diet and Breast Density
Status: Enrolling
Updated: 12/31/1969
General Clinical Research Center, The University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Soy Isoflavones and Breast Cancer Risk Reduction
Mammographic Density and Soy Isoflavones
Status: Enrolling
Updated:  12/31/1969
General Clinical Reserach Center, The University of Texas Medical Branch
mi
from
Galveston, TX
Soy Isoflavones and Breast Cancer Risk Reduction
Mammographic Density and Soy Isoflavones
Status: Enrolling
Updated: 12/31/1969
General Clinical Reserach Center, The University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
A Randomized Multicenter Trial of Neoadjuvant Taxotere (T) and Adriamycin/Cytoxan (Ac): A Validation
Status: Enrolling
Updated:  12/31/1969
Baylor Breast Center
mi
from
Houston, TX
Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients
A Randomized Multicenter Trial of Neoadjuvant Taxotere (T) and Adriamycin/Cytoxan (Ac): A Validation
Status: Enrolling
Updated: 12/31/1969
Baylor Breast Center
mi
from
Houston, TX
Click here to add this to my saved trials
Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Phase I/II Hypofractionated Radiotherapy for Prostate Cancer
Phase I/II Trial Examining Dose-per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
A Prospective Study of Intermittent Androgen Suppression (IAS) in Men With Localized Prostate Cancer Who Have Biochemical Relapse After Radiation Therapy or Radical Prostatectomy
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer
A Prospective Study of Intermittent Androgen Suppression (IAS) in Men With Localized Prostate Cancer Who Have Biochemical Relapse After Radiation Therapy or Radical Prostatectomy
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance
mi
from
Seattle, WA
Click here to add this to my saved trials
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
North Shore University Hospital
mi
from
Lake Success, NY
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
mi
from
Lake Success, NY
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Providence Alaska Medical Center
mi
from
Anchorage, AK
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Mercy San Juan Medical Center
mi
from
Carmichael, CA
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Mercy San Juan Medical Center
mi
from
Carmichael, CA
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Mercy General Hospital Radiation Oncology Center
mi
from
Sacramento, CA
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Mercy General Hospital Radiation Oncology Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Penrose-Saint Francis Healthcare
mi
from
Colorado Springs, CO
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Penrose-Saint Francis Healthcare
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Beebe Medical Center
mi
from
Lewes, DE
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Beebe Medical Center
mi
from
Lewes, DE
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Jupiter Medical Center
mi
from
Jupiter, FL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Jupiter Medical Center
mi
from
Jupiter, FL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Canton
mi
from
Canton, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Graham Hospital Association
mi
from
Canton, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Graham Hospital Association
mi
from
Canton, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
mi
from
Carthage, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Decatur Memorial Hospital
mi
from
Decatur, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Decatur Memorial Hospital
mi
from
Decatur, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Eureka Hospital
mi
from
Eureka, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Eureka Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Click here to add this to my saved trials